Tvardi Therapeutics (TVRD) Receivables Refunds: 2013-2017
Historic Receivables Refunds for Tvardi Therapeutics (TVRD) over the last 4 years, with Sep 2017 value amounting to $705,000.
- Tvardi Therapeutics' Receivables Refunds rose 6.33% to $705,000 in Q3 2017 from the same period last year, while for Sep 2017 it was $705,000, marking a year-over-year increase of 6.33%. This contributed to the annual value of $852,000 for FY2016, which is 121.88% up from last year.
- According to the latest figures from Q3 2017, Tvardi Therapeutics' Receivables Refunds is $705,000, which was up 25.89% from $560,000 recorded in Q2 2017.
- Tvardi Therapeutics' Receivables Refunds' 5-year high stood at $852,000 during Q4 2016, with a 5-year trough of $46,000 in Q1 2014.
- In the last 3 years, Tvardi Therapeutics' Receivables Refunds had a median value of $558,000 in 2017 and averaged $524,909.
- Its Receivables Refunds has fluctuated over the past 5 years, first spiked by 405.62% in 2015, then declined by 7.89% in 2017.
- Tvardi Therapeutics' Receivables Refunds (Quarterly) stood at $61,000 in 2013, then soared by 227.87% to $200,000 in 2014, then soared by 92.00% to $384,000 in 2015, then soared by 121.88% to $852,000 in 2016, then rose by 6.33% to $705,000 in 2017.
- Its last three reported values are $705,000 in Q3 2017, $560,000 for Q2 2017, and $558,000 during Q1 2017.